Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 1/20 | 0.58 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.56 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.42 |
| ▸ | S1PR2 | O95136 | 6/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 6/20 | 0.40 |
| ▸ | S1PR3 | Q99500 | 6/20 | 0.40 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.40 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4517898 | 1.00 | TYMS (0.58) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL2817555 | 1.00 | TYMS (0.58) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL4539408 | 1.00 | TYMS (0.58) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL4533342 | 1.00 | TYMS (0.58) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL4531839 | 1.00 | TYMS (0.58) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL4526564 | 1.00 | TYMS (0.58) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL4527382 | 1.00 | TYMS (0.58) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL4522106 | 1.00 | TYMS (0.58) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL4534184 | 1.00 | TYMS (0.58) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL4528496 | 1.00 | TYMS (0.58) | TYMSLPAR3LPAR2LMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12046269-B2 | Two bit memory device and method for operating the two-bit memory device and electronic component | MERCK PATENT GMBH (DE) | 2024-07-23 | — | — | US | disclosed |
| US-20230010658-A1 | ELECTRONIC SWITCHING DEVICE | MERCK PATENT GMBH (DE) | 2023-01-12 | — | — | US | disclosed |
| US-20220383924-A1 | TWO BIT MEMORY DEVICE AND METHOD FOR OPERATING THE TWO-BIT MEMORY DEVICE AND ELECTRONIC COMPONENT | MERCK PATENT GMBH (DE) | 2022-12-01 | — | — | US | disclosed |
| WO-2021078699-A1 | ELECTRONIC SWITCHING DEVICE | MERCK PATENT GMBH (DE) | 2021-04-29 | — | — | WO | disclosed |
| WO-2021078714-A1 | TWO BIT MEMORY DEVICE AND METHOD FOR OPERATING THE TWO-BIT MEMORY DEVICE AND ELECTRONIC COMPONENT | MERCK PATENT GMBH (DE) | 2021-04-29 | — | — | WO | disclosed |
| EP-3813135-A1 | TWO BIT MEMORY DEVICE AND METHOD FOR OPERATING THE TWO-BIT MEMORY DEVICE AND ELECTRONIC COMPONENT | Merck Patent GmbH (DE) | 2021-04-28 | — | — | EP | disclosed |
| EP-3813132-A1 | ELECTRONIC SWITCHING DEVICE | Merck Patent GmbH (DE) | 2021-04-28 | — | — | EP | disclosed |
| US-20090123516-A1 | DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS-THERAPEUTIC SAMS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2009-05-14 | — | — | US | disclosed |
| WO-2007019478-A2 | DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS - THERAPEUTIC SAMS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230010658-A1 | ELECTRONIC SWITCHING DEVICE | L1CAM, GRIN2B, NBAS | TYMS 3146/4885LPAR3 3888/4885LPAR2 3291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.